These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12084296)

  • 21. Diagnosis and Management of Hereditary Renal Cell Cancer.
    Menko FH; Maher ER
    Recent Results Cancer Res; 2016; 205():85-104. PubMed ID: 27075350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomics of renal cell cancer: the biology behind and the therapy ahead.
    Jones J; Libermann TA
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):685s-692s. PubMed ID: 17255294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA expression profiling of Xp11 renal cell carcinoma.
    Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
    Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal cancer: molecular mechanisms and newer therapeutic options.
    Karumanchi SA; Merchan J; Sukhatme VP
    Curr Opin Nephrol Hypertens; 2002 Jan; 11(1):37-42. PubMed ID: 11753085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal cell carcinoma: basic biology and clinical behavior.
    Franklin JR; Figlin R; Belldegrun A
    Semin Urol Oncol; 1996 Nov; 14(4):208-15. PubMed ID: 8946619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Renal cell carcinoma--any new developments?].
    Heinzer H; Huland H; Kuczyk M
    Urologe A; 1999 Sep; 38(5):423-4. PubMed ID: 10501699
    [No Abstract]   [Full Text] [Related]  

  • 27. Renal cell carcinoma: basic biology and current approaches to therapy.
    Belldegrun A; Abi-Aad AS; Figlin RA; deKernion JB
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):96-101. PubMed ID: 1948136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward a genome-based treatment landscape for renal cell carcinoma.
    Massari F; Di Nunno V; Santoni M; Gatto L; Caserta C; Morelli F; Zafarana E; Carrozza F; Mosca A; Mollica V; Iacovelli R; Sabbatini R; Porta C; Bracarda S
    Crit Rev Oncol Hematol; 2019 Oct; 142():141-152. PubMed ID: 31401421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted therapies for renal cell carcinoma.
    Posadas EM; Limvorasak S; Figlin RA
    Nat Rev Nephrol; 2017 Aug; 13(8):496-511. PubMed ID: 28691713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular biology of the clear cell renal cell carcinoma: principles for a selective treatment].
    Grande Pulido E; Martín Centeno A; Maroto Rey P; Solsona Narbón E
    Actas Urol Esp; 2007 Mar; 31(3):233-43. PubMed ID: 17658151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rational therapy for renal cell carcinoma based on its genetic targets.
    Messer J; Drabick J; Kaag M
    Adv Exp Med Biol; 2013; 779():291-308. PubMed ID: 23288645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential role for neoadjuvant therapy in renal cell carcinoma.
    Ho D; Kim HL
    Clin Adv Hematol Oncol; 2013 Dec; 11(12):777-82. PubMed ID: 24893281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The genomics of renal cell carcinoma and its role in renal mass biopsy.
    Salami SS; George AK; Udager AM
    Curr Opin Urol; 2018 Jul; 28(4):383-391. PubMed ID: 29708949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Novel biomarkers in renal cell carcinoma. Identification and functional characterization].
    Macher-Göppinger S
    Pathologe; 2015 Nov; 36 Suppl 2():201-4. PubMed ID: 26362327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-clear cell renal cell carcinoma: how new biological insight may lead to new therapeutic modalities.
    Bex A; Larkin J; Blank C
    Curr Oncol Rep; 2011 Jun; 13(3):240-8. PubMed ID: 21298371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artificial Intelligence in Pathomics and Genomics of Renal Cell Carcinoma.
    Knudsen JE; Rich JM; Ma R
    Urol Clin North Am; 2024 Feb; 51(1):47-62. PubMed ID: 37945102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
    Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal Cell Carcinoma Presenting as Carcinoma of Unknown Primary Site: Recognition of a Treatable Patient Subset.
    Greco FA; Hainsworth JD
    Clin Genitourin Cancer; 2018 Aug; 16(4):e893-e898. PubMed ID: 29610002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers in clear cell renal cell carcinoma.
    George S; Bukowski RM
    Expert Rev Anticancer Ther; 2007 Dec; 7(12):1737-47. PubMed ID: 18062748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular genetic mechanism of the kidney cancer].
    Nakaigawa N; Yao M; Kishida T; Kubota Y
    Nihon Rinsho; 2001 Jan; 59(1):104-9. PubMed ID: 11197838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.